<< Back to News

System Formulary Update
Idecabtagene Vicleucel (Abecma)

Situation

Idecabtagene Vicleucel (Abecma) injection was approved for addition to the health system formulary at the June 2021 System Pharmacy and Therapeutics Committee meeting.

Background

The following medication was reviewed: Idecabtagene Vicleucel (Abecma)

 Assessment/Recommendation

Change effective: Tuesday August 17, 2021    

System P&T voted to include the following products on the UNC Health Medication Formulary:

• Idecabtagene Vicleucel (Abecma) injection

Note: Stock of this formulary product may vary at individual entities